Adar Poonawalla

COVID: AstraZeneca pledges USD 250,000 as humanitarian aid to India

11:59 pm May 11, 2021

New Delhi: Drug major AstraZeneca on Tuesday said it has pledged USD 250,000 (over Rs 1.8 crore) in humanitarian aid to India to support relief activities amid the second wave of COVID-19 sweeping across the country. The aid to India is part of the USD 1 million which the British-Swedish multinational has earmarked for relief initiatives across communities which have been […]

Delhi has less than a day’s stock of Covaxin for 45-plus age group: Atishi

Bharat Biotech hits outs at critics, says carried out ‘200 pc honest’ trials of corona vaccine

10:36 pm January 4, 2021

Hyderabad : Amid questions raised by industry experts and opposition parties on the emergency approval to its coronavirus vaccine Covaxin without publication of efficacy data, Bharat Biotech’s chairman on Monday hit out at critics saying his firm had carried out ”200 per cent honest clinical trials”. Speaking to reporters at a virtual press conference, Krishna Ella said his firm has a […]

India approves Oxford’s, Bharat Biotech’s COVID-19 vaccines for restricted emergency use

4:50 pm January 3, 2021

New Delhi: India’s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. The Drugs Controller General of India (DCGI) granted the approval on the basis of recommendations by a COVID-19 Subject Expert Committee (SEC) […]

Already produced 40-50 million dosages of Covishield vaccine: Serum Institute

8:54 pm December 28, 2020

New Delhi: Serum Institute of India has already produced around 50 million dosages of the Oxford-AstraZeneca COVID-19 vaccine ‘Covishield’ and plans to scale it up to 100 million by March next year even as it awaits approval for emergency use authorisation, a top company official said on Monday. The company, which has launched the country’s […]

In process to apply for emergency use licensure for COVID-19 vaccine: Adar Poonawalla

10:23 pm November 28, 2020

New Delhi: Vaccine major Serum Institute of India (SII) on Saturday said it is in the process of applying for an emergency use licensure for the AstraZeneca-Oxford’s COVID-19 vaccine candidate in India in the next two weeks. Addressing a virtual press conference on the visit of Prime Minister Narendra Modi to the company’s Pune facility, Serum Institute […]

Next Posts >>